[KongchangAI]
Unverified85% confidenceFactTime unknown

UC-II(未变性II型胶原蛋白)通过口服免疫耐受机制起效,每日有效剂量仅40mg,远低于水解胶原蛋白的克级剂量,二者作用原理完全不同

1
Sources
85%
Confidence
Long-term
Relevance
-
First Seen

Sources

Related Entities

Related Claims

Cite This Claim

Stable URI
https://kongchang.com/claim/265453
API
curl https://kongchang.com/api/v1/knowledge/claims/265453
MCP
get_claim(id=265453)